Pune: The State Minister for Health and Welfare of the Bharati Pawar family told Thursday that the anti-covid vaccine producers were set to increase production in the next three months and there would be no shortage of supply to the country to complete the first 100% first-dose inoculation .
India reached the main milestone in the vaccination program against Covid-19 because the cumulative dose managed in the country exceeded the 100 crore sign on Thursday.
The minister said the goal was to continue to increase vaccination to cover all 944 million adults (94 crore) earlier.
“Previous supply was 2.5 lakh vaccine doses per day.
Now, it has risen to 40-50 doses of the lakh vaccine a day.
We currently have around 70% of the first dosage and 30% seconds of vaccines.
With adequate availability, the target will speed up Vaccination in all countries left behind, “he said.
“Himachal Pradesh, Goa, Dadar and Nagar Haveli have shown good progress with the first dose coverage of 97-100%.
Great countries such as Uttar Pradesh and Maharashtra also tried to increase the speed of vaccination,” said Dr.
Pawar.
Indian Serum Institute CEO Adar Poonawalla told TI that the United States “was very happy” with the level of production and that the level of stock was comfortable throughout the country.
“We produce more than 220 million doses a month.
India is fully safe as far as it concerns the vaccine stock and everything goes well,” he said.
A Bharat Biotech official said the manufacturing scale was carried out in stages in several facilities in Hyderabad (Telangana), Malur (Karnataka) and Ankleshwar (Gujarat).
“The target is to achieve our goal of 1 billion doses of covaxin per year.
The company now produces 30-40 million doses a month.
We will touch 50 million at the end of this month,” the official said.
Bharat Biotech has issued a statement from the CMD Krishna Ella which states that reaching a sign of 1 billion in nine months is “extraordinary achievement”.
Bharat Biotech Joint MD Suchitra Ella has been grateful to all academic collaborators, industrial partners, stakeholders, suppliers, and employees because it allows them to maximize efforts to send covaxin.
The National Task Force Member Dr.
N K Arora told TI that the country would have around 90 doses of crore available for the program in the next three months.
“There are no shortcomings.
More vaccines will soon be added to the existing range,” he said.
Bad Effects After immunization (AEFI) during Covid vaccination drive throughout the country is very low so far.
An official of the Senior State Department of Health said at almost nine Crore Jab provided in the state until recently, the percentage of AEFIS which was reported was only 0.008%, which was a minuscule.